INDBInternet News Database 2.5 Updated 1 min ago · 293 sources Show or hide images Light or dark

Liso-Cel in 3L Follicular Lymphoma: Has the Debate Ended?

1 source1 article First seen Updated United States Truth score 38

Save Like Comments Compare coverage

Summary

A recent commentary says longer follow-up of TRANSCEND follicular lymphoma makes liso-cel the best third-line option for patients who can get it. But caveats remain.

Description from Medscape.

Who is covering this

  1. Medscape Center Factuality: Mostly factual US
    Liso-Cel in 3L Follicular Lymphoma: Has the Debate Ended?

    A recent commentary says longer follow-up of TRANSCEND follicular lymphoma makes liso-cel the best third-line option for patients who can get it. But caveats remain.

Comments

Comments need JavaScript.